In vitro bioactivity and antibacterial properties of bismuth oxide modified bioactive glasses
Source abstract
Abstract
Chronic osteomyelitis, a bone infection caused by bacteria, requires extensive parenteral treatments. With an aim to develop bioactive glass with antibacterial properties to resist such infections, bioactive glasses with bismuth oxide as the dopant in various amounts up to 8 wt% were prepared. X-ray diffraction patterns and Fourier-transform infrared spectra of glass samples after immersion in simulated body fluid showed the presence of hydroxyapatite (HAp) and hydroxyl carbonate apatite for all samples except with the one having Bi2O3substitution of 8 wt%. In vitro cell proliferation by MTT assay studies using a mouse fibroblast cell line (NIH3T3) have also been carried out. Primary antimicrobial activity of the glass particles was analyzed againstEscherichia coli(E. coli) using broth microdilution method which exhibited bacteriostatic effects and bactericidal properties in selected samples. The combination of bioactivity, cell proliferation, and antibacterial properties of selected Bismuth-containing bioactive glasses could be exploited in treating bone-related infections.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Endodontics and Root Canal Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. 10.1016/j.joen.2009.09.01010.1016/j.joen.2009.09.010 ↗
2. 10.1590/S1516-8913201400500000710.1590/S1516-89132014005000007 ↗
3. 10.4236/aim.2016.61007610.4236/aim.2016.610076 ↗
4. 10.1186/1752-153X-5-7410.1186/1752-153X-5-74 ↗
5. 10.1002/jbm.1028010.1002/jbm.10280 ↗
6. 10.1111/j.1365-2591.2009.01660.x10.1111/j.1365-2591.2009.01660.x ↗
7. 10.1016/j.joen.2009.09.00610.1016/j.joen.2009.09.006 ↗
8. 10.1515/bglass-2016-000410.1515/bglass-2016-0004 ↗
9. 10.1039/c2jm14674f10.1039/c2jm14674f ↗
10. 10.1093/jac/48.suppl_1.510.1093/jac/48.suppl_1.5 ↗
11. 10.1016/j.biomaterials.2003.09.00110.1016/j.biomaterials.2003.09.001 ↗
12. 10.1016/j.biomaterials.2004.07.02410.1016/j.biomaterials.2004.07.024 ↗
13. 10.4236/ijcm.2012.3101010.4236/ijcm.2012.31010 ↗
14. 10.1007/s10853-017-0915-y10.1007/s10853-017-0915-y ↗
15. 10.3389/fbioe.2015.0019410.3389/fbioe.2015.00194 ↗
16. 10.1016/j.actbio.2011.01.00410.1016/j.actbio.2011.01.004 ↗
17. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
18. Structural investigation of CuO–Bi2O3–B2O3 glasses by FT-IR, Raman and UV-VIS spectroscopies
19. 10.1016/S0142-9612(00)00330-610.1016/S0142-9612(00)00330-6 ↗
20. The story of Bioglass®
21. 10.4236/ajac.2014.51612110.4236/ajac.2014.516121 ↗
22. Increased osteoblast viability at alkaline pH in vitro provides a new perspective on bone regeneration
23. 10.1128/AAC.46.6.1940-1945.200210.1128/AAC.46.6.1940-1945.2002 ↗
24. 10.1007/s11837-015-1467-810.1007/s11837-015-1467-8 ↗
25. In vitro biological and tribological properties of transparent magnesium aluminate (Spinel) and aluminum oxynitride (ALON®)
26. 10.1016/j.ceramint.2013.06.06210.1016/j.ceramint.2013.06.062 ↗
27. 10.1002/jbm.a.1005210.1002/jbm.a.10052 ↗
28. 10.1111/j.1551-2916.2011.05012.x10.1111/j.1551-2916.2011.05012.x ↗
29. Medical use of bismuth: The two sides of the coin
30. 10.1016/j.msec.2014.05.00410.1016/j.msec.2014.05.004 ↗
31. 10.1046/j.1365-2036.11.s1.13.x10.1046/j.1365-2036.11.s1.13.x ↗
32. 10.1016/S0140-6736(04)16727-510.1016/S0140-6736(04)16727-5 ↗
33. 10.1002/jbm.82024060710.1002/jbm.820240607 ↗
34. 10.1016/j.cej.2016.11.11610.1016/j.cej.2016.11.116 ↗
35. Carbonated apatite, type-A or type-B?
36. 10.1128/AAC.00196-1510.1128/AAC.00196-15 ↗
37. 10.1093/clinids/12.Supplement_1.S310.1093/clinids/12.Supplement_1.S3 ↗
38. Infrared absorption spectroscopy of some bio-glasses before and after immersion in various solutions
39. 10.1016/S0142-9612(02)00577-X10.1016/S0142-9612(02)00577-X ↗
40. In vivo behaviour of glasses in the SiO2–Na2O–CaO–P2O5–Al2O3–B2O3 system
41. 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G ↗
42. 10.1086/53359210.1086/533592 ↗
43. 10.1111/wrr.1252610.1111/wrr.12526 ↗